Endoscopic Removal of Tumors of Nose and Paranasal Sinuses: Our Experience

Background: The endonasal endoscopic surgery has stood the test of time in managing inflammatory as well as other diseases affecting nose and paranasal sinuses. Objective: To report our experience with endonasal endoscopic surgery of benign tumors and tumor-like conditions of the nose and paranasal sinuses. Methods: The medical records of 92 patients with tumors and tumor-like conditions, who had undergone endoscopic surgery for removal of their lesions between 1999 and 2010, were retrospectively studied. Results: The study included a total of 92 patients. Out of these patients, there were 24 with inverted papilloma, six juvenile nasopharyngeal angiofibroma, 10 intranasal hemangioma,10 fibro-osseous lesions, four olfactory neuroblastoma, two each schwannoma and neurofibroma, one glioma, two plasmacytoma, two pleomorphic adenoma, 11 pyogenic granuloma, 14 mucoceles and four giant cell reparative granuloma. The patients had a follow-up ranging from 6 to 78 months (mean: 42). Follow-up assessment included endoscopy and yearly CT scans. Three cases of recurrent tumor—two inverted papilloma and one mucocele were noted. These were managed endoscopically. There were no major complication encountered in this study and minor complications were orbital fat protrusion 8, synechiae 6 cases. Conclusion: Benign tumors and tumor-like conditions of the nose and paranasal sinuses can be managed with endonasal endoscopic surgery with minimal morbidity.